{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:18:02Z","timestamp":1771481882268,"version":"3.50.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12016-015-8505-8","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T06:16:49Z","timestamp":1444198609000},"page":"347-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review"],"prefix":"10.1007","volume":"49","author":[{"given":"Isabel","family":"Almeida","sequence":"first","affiliation":[]},{"given":"Sara Vieira","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Ana Raquel","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"Ivone","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Vasconcelos","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Lima","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,10,7]]},"reference":[{"issue":"Suppl 3","key":"8505_CR1","first-page":"iii3","volume":"48","author":"DJ Abraham","year":"2009","unstructured":"Abraham DJ, Krieg T, Distler J, Distler O (2009) Overview of pathogenesis of systemic sclerosis. Rheumatology 48(Suppl 3):iii3\u2013iii7. doi: 10.1093\/rheumatology\/ken481","journal-title":"Rheumatology"},{"key":"8505_CR2","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2011","unstructured":"Gabrielli A, Avvedimento EV, Krieg T (2011) Scleroderma. N Engl J Med 360:1989\u20132003. doi: 10.1056\/NEJMra0806188","journal-title":"N Engl J Med"},{"key":"8505_CR3","first-page":"105","volume":"4","author":"D Pattanaik","year":"2011","unstructured":"Pattanaik D, Brown M, Postlethwaite AE (2011) Vascular involvement in systemic sclerosis (scleroderma). J Inflamm Res 4:105\u2013125. doi: 10.2147\/JIR.S18145","journal-title":"J Inflamm Res"},{"key":"8505_CR4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1568-9972(03)00004-1","volume":"2","author":"MC Tamby","year":"2003","unstructured":"Tamby MC, Chanseaud Y, Guillevin L, Mouthon L (2003) New insights into the pathogenesis of systemic sclerosis. Autoimmun Rev 2:152\u2013157. doi: 10.1016\/S1568-9972(03)00004-1","journal-title":"Autoimmun Rev"},{"key":"8505_CR5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2010.09.016","volume":"10","author":"C Chizzolini","year":"2011","unstructured":"Chizzolini C, Brembilla NC, Montanari E, Truchetet ME (2011) Fibrosis and immune dysregulation in systemic sclerosis. Autoimmun Rev 10:276\u2013281. doi: 10.1016\/j.autrev.2010.09.016","journal-title":"Autoimmun Rev"},{"key":"8505_CR6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12016-007-8009-2","volume":"33","author":"N Yazawa","year":"2007","unstructured":"Yazawa N, Fujimoto M, Tamaki K (2007) Recent advances on pathogenesis and therapies in systemic sclerosis. Clin Rev Allergy Immunol 33:107\u2013112. doi: 10.1007\/s12016-007-8009-2","journal-title":"Clin Rev Allergy Immunol"},{"key":"8505_CR7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12016-008-8106-x","volume":"36","author":"FM Wigley","year":"2009","unstructured":"Wigley FM (2009) Vascular disease in scleroderma. Clin Rev Allergy Immunol 36:150\u2013175. doi: 10.1007\/s12016-008-8106-x","journal-title":"Clin Rev Allergy Immunol"},{"key":"8505_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12016-010-8200-8","volume":"40","author":"L Guillevin","year":"2010","unstructured":"Guillevin L (2010) A contemporary update on scleroderma. Clin Rev Allergy Immunol 40:75\u201377. doi: 10.1007\/s12016-010-8200-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"8505_CR9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117:557\u2013567. doi: 10.1172\/JCI31139","journal-title":"J Clin Invest"},{"key":"8505_CR10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","volume":"10","author":"YY Ho","year":"2014","unstructured":"Ho YY, Lagares D, Tager AM, Kapoor M (2014) Fibrosis\u2014a lethal component of systemic sclerosis. Nat Rev Rheumatol 10:390\u2013402. doi: 10.1038\/nrrheum.2014.53","journal-title":"Nat Rev Rheumatol"},{"key":"8505_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2362.1988.tb01158.x","volume":"18","author":"K Scharffetter","year":"1988","unstructured":"Scharffetter K, Lankat-Buttgereit B, Krieg T (1988) Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Investig 18:9\u201317","journal-title":"Eur J Clin Investig"},{"key":"8505_CR12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.20315","volume":"50","author":"LI Sakkas","year":"2004","unstructured":"Sakkas LI, Platsoucas CD (2004) Is systemic sclerosis an antigen-driven T cell disease? Arthritis Rheum 50:1721\u20131733. doi: 10.1002\/art.20315","journal-title":"Arthritis Rheum"},{"key":"8505_CR13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-140-2-200401200-00013","volume":"140","author":"SA Jimenez","year":"2004","unstructured":"Jimenez SA, Derk CT (2004) Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 140:37\u201350. doi: 10.7326\/0003-4819-140-2-200401200-00013","journal-title":"Ann Intern Med"},{"key":"8505_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11926-007-0012-3","volume":"9","author":"F Boin","year":"2007","unstructured":"Boin F, Rosen A (2007) Autoimmunity in systemic sclerosis: current concepts. Curr Rheumatol Rep 9:165\u2013172","journal-title":"Curr Rheumatol Rep"},{"key":"8505_CR15","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","volume":"65","author":"M Matucci-Cerinic","year":"2013","unstructured":"Matucci-Cerinic M, Kahaleh B, Wigley FM (2013) Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 65:1953\u20131962. doi: 10.1002\/art.37988","journal-title":"Arthritis Rheum"},{"key":"8505_CR16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12026-011-8222-1","volume":"50","author":"P Fuschiotti","year":"2011","unstructured":"Fuschiotti P (2011) (2011) CD8+ T cells in systemic sclerosis. Immunol Res 50:188\u2013194. doi: 10.1007\/s12026-011-8222-1","journal-title":"Immunol Res"},{"key":"8505_CR17","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","volume":"51","author":"S O\u2019Reilly","year":"2012","unstructured":"O\u2019Reilly S, H\u00fcgle T, van Laar JM (2012) T cells in systemic sclerosis: a reappraisal. Rheumatology 51:1540\u20131549. doi: 10.1093\/rheumatology\/kes090","journal-title":"Rheumatology"},{"key":"8505_CR18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","volume":"35","author":"VD Steen","year":"2005","unstructured":"Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35:35\u201342. doi: 10.1016\/j.semarthrit.2005.03.005","journal-title":"Semin Arthritis Rheum"},{"key":"8505_CR19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/01.bor.0000245726.33006.c3","volume":"18","author":"FC Arnett","year":"2006","unstructured":"Arnett FC (2006) Is scleroderma an autoantibody mediated disease? Curr Opin Rheumatol 18:579\u2013581","journal-title":"Curr Opin Rheumatol"},{"key":"8505_CR20","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","volume":"50","author":"S Sato","year":"2004","unstructured":"Sato S, Fujimoto M, Hasegawa M, Takehara K (2004) Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum 50:1918\u20131927. doi: 10.1002\/art.20274","journal-title":"Arthritis Rheum"},{"key":"8505_CR21","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/art.22847","volume":"56","author":"R Lafyatis","year":"2007","unstructured":"Lafyatis R, O'Hara C, Feghali-Bostwick CA, Matteson E (2007) B cell infiltration in systemic sclerosis-associated interstitial lung disease. Arthritis Rheum 56:3167\u20133168. doi: 10.1002\/art.22847","journal-title":"Arthritis Rheum"},{"key":"8505_CR22","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","volume":"354","author":"SS Baroni","year":"2006","unstructured":"Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A (2006) Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354:2667\u20132676. doi: 10.1056\/NEJMoa052955","journal-title":"N Engl J Med"},{"key":"8505_CR23","doi-asserted-by":"crossref","first-page":"R168","DOI":"10.1186\/ar4352","volume":"15","author":"A Francois","year":"2013","unstructured":"Francois A, Chatelus E, Wachsmann D, Sibilia J, Bahram S, Alsaleh G, Gottenberg J-E (2013) B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis. Arthitis Res Ther 15:R168. doi: 10.1186\/ar4352","journal-title":"Arthitis Res Ther"},{"key":"8505_CR24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1523-1747.2003.12097.x","volume":"120","author":"S Sato","year":"2003","unstructured":"Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K (2003) Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Investig Dermatol 120:542\u2013547","journal-title":"J Investig Dermatol"},{"key":"8505_CR25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","volume":"27","author":"AD Roumm","year":"1984","unstructured":"Roumm AD, Whiteside TL, Medsger TA, Rodnan GP (1984) Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum 27:645\u2013653","journal-title":"Arthritis Rheum"},{"key":"8505_CR26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711660307","volume":"166","author":"RJ Prescott","year":"1992","unstructured":"Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P (1992) Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 166:255\u2013263","journal-title":"J Pathol"},{"key":"8505_CR27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/07853890601098152","volume":"39","author":"C Chizzolini","year":"2007","unstructured":"Chizzolini C (2007) Update on pathophysiology of scleroderma with special reference to immunoinflammatory events. Ann Med 39:42\u201353. doi: 10.1080\/07853890601098152","journal-title":"Ann Med"},{"key":"8505_CR28","first-page":"355","volume":"104","author":"TL Whiteside","year":"1984","unstructured":"Whiteside TL, Buckingham RB, Prince RK, Rodnan GP (1984) Products of activated mononuclear cells modulate accumulation of collagen by normal dermal and scleroderma fibroblasts in culture. J Lab Clin Med 104:355\u2013369","journal-title":"J Lab Clin Med"},{"key":"8505_CR29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/art.1780200410","volume":"20","author":"R Fleischmajer","year":"1977","unstructured":"Fleischmajer R, Perlish JS, Reeves JR (1977) Cellular infiltrates in scleroderma skin. Arthritis Rheum 20:975\u2013984","journal-title":"Arthritis Rheum"},{"key":"8505_CR30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jcp.2004.019224","volume":"58","author":"MR Hussein","year":"2005","unstructured":"Hussein MR, Hassan HI, Hofny ERM, Elkholy M, Fatehy NA, Abd Elmoniem AEA, Ezz El-Din AM, Afifi OA, Rashed HG (2005) Alterations of mononuclear inflammatory cells, CD4\/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis. J Clin Pathol 58:178\u2013184. doi: 10.1136\/jcp.2004.019224","journal-title":"J Clin Pathol"},{"key":"8505_CR31","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2004.027094","volume":"64","author":"A Kalogerou","year":"2005","unstructured":"Kalogerou A, Gelou E, Mountantonakis S, Settas L, Zafiriou E, Sakkas L (2005) Early T cell activation in the skin from patients with systemic sclerosis. Ann Rheum Dis 64:1233\u20131235. doi: 10.1136\/ard.2004.027094","journal-title":"Ann Rheum Dis"},{"key":"8505_CR32","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2741\/1654","volume":"10","author":"CM Artlett","year":"2005","unstructured":"Artlett CM (2005) Immunology of systemic sclerosis. Front Biosci 10:1707\u20131719. doi: 10.2741\/1654","journal-title":"Front Biosci"},{"key":"8505_CR33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/art.37706","volume":"65","author":"P Fuschiotti","year":"2013","unstructured":"Fuschiotti P, Larregina AT, Ho J, Feghali-Bostwick C, Medsger TA (2013) Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum 65:236\u2013246","journal-title":"Arthritis Rheum"},{"key":"8505_CR34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/1529-0131(199802)41:2<327::AID-ART17>3.0.CO;2-S","volume":"41","author":"R Giacomelli","year":"1998","unstructured":"Giacomelli R, Matucci-Cerinic M, Cipriani P, Ghersetich I, Lattanzio R, Pavan A, Pignone A, Cagnoni ML, Lotti T, Tonietti G (1998) Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients. Arthritis Rheum 41:327\u2013334. doi: 10.1002\/art.37706","journal-title":"Arthritis Rheum"},{"key":"8505_CR35","first-page":"283","volume":"32","author":"V Riccieri","year":"2005","unstructured":"Riccieri V, Parisi G, Spadaro A, Scrivo R, Barone F, Moretti T, Bernardini G, Strom R, Taccari E, Valesini G (2005) Reduced circulating natural killer T cells and gamma\/delta T cells in patients with systemic sclerosis. J Rheumatol 32:283\u2013286","journal-title":"J Rheumatol"},{"key":"8505_CR36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clim.2010.06.004","volume":"137","author":"A Giovannetti","year":"2010","unstructured":"Giovannetti A, Rosato E, Renzi C, Maselli A, Gambardella L, Giammarioli AM, Palange P, Paoletti P, Pisarri S, Salsano F, Malorni W, Pierdominici M (2010) Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes. Clin Immunol 137:122\u2013133. doi: 10.1016\/j.clim.2010.06.004","journal-title":"Clin Immunol"},{"key":"8505_CR37","volume":"4","author":"TRDJ Radstake","year":"2009","unstructured":"Radstake TRDJ, van Bon L, Broen J, Wenink M, Santegoets K, Deng Y, Hussaini A, Simms R, Cruikshank WW, Lafyatis R (2009) Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. PLoS One 4, e5981. doi: 10.1371\/journal.pone.0005981","journal-title":"PLoS One"},{"key":"8505_CR38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1183\/09031936.95.08020266","volume":"8","author":"AU Wells","year":"1995","unstructured":"Wells AU, Lorimer S, Majumdar S, Harrison NK, Corrin B, Black CM, Jeffery PK, du Bois RM (1995) Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium. Eur Respir J 8:266\u2013271","journal-title":"Eur Respir J"},{"key":"8505_CR39","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0954-6111(98)90231-1","volume":"92","author":"J Domaga\u0142a-Kulawik","year":"1998","unstructured":"Domaga\u0142a-Kulawik J, Hoser G, Doboszy\u0144ska A, Kawiak J, Droszcz W (1998) Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLCO impairment. Respir Med 92:1295\u20131301","journal-title":"Respir Med"},{"key":"8505_CR40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0198-8859(96)00091-2","volume":"48","author":"VV Yurovsky","year":"1996","unstructured":"Yurovsky VV, Wigley FM, Wise RA, White B (1996) Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis. Hum Immunol 48:84\u201397","journal-title":"Hum Immunol"},{"key":"8505_CR41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1521-6616(03)00062-7","volume":"108","author":"F Ingegnoli","year":"2003","unstructured":"Ingegnoli F, Trabattoni D, Saresella M, Fantini F, Clerici M (2003) Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis. Clin Immunol 108:21\u201328. doi: 10.1016\/S1521-6616(03)00062-7","journal-title":"Clin Immunol"},{"key":"8505_CR42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/2047-783X-15-1-44","volume":"15","author":"T Gambichler","year":"2010","unstructured":"Gambichler T, Tigges C, Burkert B, H\u00f6xtermann S, Altmeyer P, Kreuter A (2010) Absolute count of T and B lymphocyte subsets is decreased in systemic sclerosis. Eur J Med Res 15:44\u201346. doi: 10.1186\/2047-783X-15-1-44","journal-title":"Eur J Med Res"},{"key":"8505_CR43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02229871","volume":"13","author":"R Gorla","year":"1994","unstructured":"Gorla R, Air\u00f2 P, Malagoli A, Carella G, Prati E, Brugnoni D, Franceschini F, Cattaneo R (1994) CD4+ and CD8+ subsets: naive and memory cells in the peripheral blood of patients with systemic sclerosis. Clin Rheumatol 13:83\u201387","journal-title":"Clin Rheumatol"},{"key":"8505_CR44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.52.4.272","volume":"52","author":"U Fiocco","year":"1993","unstructured":"Fiocco U, Rosada M, Cozzi L, Ortolani C, De Silvestro G, Ruffatti A, Cozzi E, Gallo C, Todesco S (1993) Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity. Ann Rheum Dis 52:272\u2013277","journal-title":"Ann Rheum Dis"},{"key":"8505_CR45","first-page":"87","volume":"13","author":"LP Ercole","year":"2003","unstructured":"Ercole LP, Malvezzi M, Boaretti AC, Utiyama SR, Rachid A (2003) Analysis of lymphocyte subpopulations in systemic sclerosis. J Investig Allergol Clin Immunol 13:87\u201393","journal-title":"J Investig Allergol Clin Immunol"},{"key":"8505_CR46","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/art.24432","volume":"60","author":"P Fuschiotti","year":"2009","unstructured":"Fuschiotti P, Medsger TA, Morel PA (2009) Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. Arthritis Rheum 60:1119\u20131128. doi: 10.1002\/art.24432","journal-title":"Arthritis Rheum"},{"key":"8505_CR47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22:633\u2013640. doi: 10.1016\/S1471-4906(01)02060-9","journal-title":"Trends Immunol"},{"key":"8505_CR48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2567.2010.03360.x","volume":"131","author":"N Schleinitz","year":"2010","unstructured":"Schleinitz N, V\u00e9ly F, Harl\u00e9 JR, Vivier E (2010) Natural killer cells in human autoimmune diseases. Immunology 131:451\u2013458. doi: 10.1111\/j.1365-2567.2010.03360.x","journal-title":"Immunology"},{"key":"8505_CR49","first-page":"27","volume":"5","author":"A Poggi","year":"2014","unstructured":"Poggi A, Zocchi MR (2014) NK cell autoreactivity and autoimmune diseases. Front Immunol 5:27. doi: 10.3389\/fimmu.2014.00027","journal-title":"Front Immunol"},{"key":"8505_CR50","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.0022-202X.2005.23767.x","volume":"125","author":"M Horikawa","year":"2005","unstructured":"Horikawa M, Hasegawa M, Komura K, Hayakawa I, Yanaba K, Matsushita T, Takehara K, Sato S (2005) Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity. J Investig Dermatol 125:731\u2013737. doi: 10.1111\/j.0022-202X.2005.23767","journal-title":"J Investig Dermatol"},{"key":"8505_CR51","first-page":"148293","volume":"2014","author":"JM L\u00f3pez-Cacho","year":"2014","unstructured":"L\u00f3pez-Cacho JM, Gallardo S, Posada M, Aguerri M, Calzada D, Mayayo T, Gonz\u00e1lez-Rodr\u00edguez ML, Rabasco AM, Lahoz C, C\u00e1rdaba B (2014) Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease. BioMed Res Int 2014:148293. doi: 10.1155\/2014\/148293","journal-title":"BioMed Res Int"},{"key":"8505_CR52","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000163963","volume":"63","author":"A Wanchu","year":"1995","unstructured":"Wanchu A, Singh VK, Yadav VS, Biswas S, Misra R, Agarwal SS (1995) Lack of natural killer cell augmentation in vitro by human interferon gamma in a subset of patients with systemic sclerosis. Pathobiol J Immunopathol Mol Cell Biol 63:288\u2013292","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"},{"key":"8505_CR53","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/art.20216","volume":"50","author":"T Momot","year":"2004","unstructured":"Momot T, Koch S, Hunzelmann N, Krieg T, Ulbricht K, Schmidt RE, Witte T (2004) Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 50:1561\u20131565. doi: 10.1002\/art.20216","journal-title":"Arthritis Rheum"},{"key":"8505_CR54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jmcb\/mjp001","volume":"1","author":"YY Wan","year":"2009","unstructured":"Wan YY, Flavell RA (2009) How diverse\u2014CD4 effector T cells and their functions. J Mol Cell Biol 1:20\u201336. doi: 10.1093\/jmcb\/mjp001","journal-title":"J Mol Cell Biol"},{"key":"8505_CR55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn TA (2004) Fibrotic disease and the T(H)1\/T(H)2 paradigm. Nat Rev Immunol 4:583\u2013594. doi: 10.1038\/nri1412","journal-title":"Nat Rev Immunol"},{"key":"8505_CR56","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5114\/pdia.2014.40954","volume":"31","author":"AG Shabgah","year":"2014","unstructured":"Shabgah AG, Fattahi E, Shahneh FZ (2014) Interleukin-17 in human inflammatory diseases. Postepy Dermatol Alergol 31:256\u2013261. doi: 10.5114\/pdia.2014.40954","journal-title":"Postepy Dermatol Alergol"},{"key":"8505_CR57","author":"I Raphael","year":"2014","unstructured":"Raphael I, Nalawade S, Eagar TN, Forsthuber TG (2014) T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. doi: 10.1016\/j.cyto.2014.09.011","journal-title":"Cytokine"},{"key":"8505_CR58","doi-asserted-by":"crossref","first-page":"936270","DOI":"10.1155\/2014\/936270","volume":"2014","author":"W O\u2019Connor","year":"2014","unstructured":"O\u2019Connor W, Esplugues E, Huber S (2014) The role of TH17-associated cytokines in health and disease. J Immunol Res 2014:936270. doi: 10.1155\/2014\/936270","journal-title":"J Immunol Res"},{"key":"8505_CR59","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/art.22927","volume":"56","author":"Y Parel","year":"2007","unstructured":"Parel Y, Aurrand-Lions M, Scheja A, Dayer J-M, Roosnek E, Chizzolini C (2007) Presence of CD4 + CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum 56:3459\u20133467. doi: 10.1002\/art.22927","journal-title":"Arthritis Rheum"},{"key":"8505_CR60","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L","volume":"42","author":"SP Atamas","year":"1999","unstructured":"Atamas SP, Yurovsky VV, Wise R, Wigley FM, Goter Robinson CJ, Henry P, Alms WJ, White B (1999) Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum 42:1168\u20131178","journal-title":"Arthritis Rheum"},{"key":"8505_CR61","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/art.30489","volume":"63","author":"TA Medsger","year":"2011","unstructured":"Medsger TA, Ivanco DE, Kardava L, Morel PA, Lucas MR, Fuschiotti P (2011) GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production. Arthritis Rheum 63:1738\u20131747. doi: 10.1002\/art.30489","journal-title":"Arthritis Rheum"},{"key":"8505_CR62","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1684\/ecn.2013.0325","volume":"23","author":"NC Brembilla","year":"2012","unstructured":"Brembilla NC, Chizzolini C (2012) T cell abnormalities in systemic sclerosis with a focus on Th17 cells. Eur Cytokine Netw 23:128\u2013139. doi: 10.1684\/ecn.2013.0325","journal-title":"Eur Cytokine Netw"},{"key":"8505_CR63","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","volume":"188","author":"T Nakashima","year":"2012","unstructured":"Nakashima T, Jinnin M, Yamane K, Honda N, Kajihara I, Makino T, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2012) Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. J Immunol 188:3573\u20133583. doi: 10.4049\/jimmunol.1100591","journal-title":"J Immunol"},{"key":"8505_CR64","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar4334","volume":"15","author":"NC Brembilla","year":"2013","unstructured":"Brembilla NC, Montanari E, Truchetet M-E, Raschi E, Meroni P, Chizzolini C (2013) Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts. Arthritis Res Ther 15:R151. doi: 10.1186\/ar4334","journal-title":"Arthritis Res Ther"},{"key":"8505_CR65","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3486","volume":"13","author":"M-E Truchetet","year":"2011","unstructured":"Truchetet M-E, Brembilla NC, Montanari E, Allanore Y, Chizzolini C (2011) Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 13:R166. doi: 10.1186\/ar3486","journal-title":"Arthritis Res Ther"},{"key":"8505_CR66","volume":"4","author":"TRDJ Radstake","year":"2009","unstructured":"Radstake TRDJ, van Bon L, Broen J, Hussiani A, Hesselstrand R, Wuttge DM, Deng Y, Simms R, Lubberts E, Lafyatis R (2009) The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One 4, e5903. doi: 10.1371\/journal.pone.0005903","journal-title":"PLoS One"},{"key":"8505_CR67","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clim.2011.01.013","volume":"139","author":"D Fenoglio","year":"2011","unstructured":"Fenoglio D, Battaglia F, Parodi A, Stringara S, Negrini S, Panico N, Rizzi M, Kalli F, Conteduca G, Ghio M, De Palma R, Indiveri F, Filaci G (2011) Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. Clin Immunol Orlando Fla 139:249\u2013257. doi: 10.1016\/j.clim.2011.01.013","journal-title":"Clin Immunol Orlando Fla"},{"key":"8505_CR68","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar4430","volume":"16","author":"X Yang","year":"2014","unstructured":"Yang X, Yang J, Xing X, Wan L, Li M (2014) Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction. Arthritis Res Ther 16:R4. doi: 10.1186\/ar4430","journal-title":"Arthritis Res Ther"},{"key":"8505_CR69","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","volume":"43","author":"K Kurasawa","year":"2000","unstructured":"Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y, Takabayashi K, Iwamoto I (2000) Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 43:2455\u20132563. doi: 10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","journal-title":"Arthritis Rheum"},{"key":"8505_CR70","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/art.30159","volume":"63","author":"E Hsu","year":"2011","unstructured":"Hsu E, Shi H, Jordan RM, Lyons-Weiler J, Pilewski JM, Feghali-Bostwick CA (2011) Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum 63:783\u2013794. doi: 10.1002\/art.30159","journal-title":"Arthritis Rheum"},{"key":"8505_CR71","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/art.37860","volume":"65","author":"M-E Truchetet","year":"2013","unstructured":"Truchetet M-E, Brembilla N-C, Montanari E, Lonati P, Raschi E, Zeni S, Fontao L, Meroni P-L, Chizzolini C (2013) Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement. Arthritis Rheum 65:1347\u20131356","journal-title":"Arthritis Rheum"},{"key":"8505_CR72","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","volume":"50","author":"M Murata","year":"2008","unstructured":"Murata M, Fujimoto M, Matsushita T, Hamaguchi Y, Hasegawa M, Takehara K, Komura K, Sato S (2008) Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? J Dermatol Sci 50:240\u2013242. doi: 10.1016\/j.jdermsci.2008.01.001","journal-title":"J Dermatol Sci"},{"key":"8505_CR73","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","volume":"11","author":"P Gourh","year":"2009","unstructured":"Gourh P, Arnett FC, Assassi S, Tan FK, Huang M, Diekman L, Mayes MD, Reveille JD, Agarwal SK (2009) Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations. Arthritis Res Ther 11:R147. doi: 10.1186\/ar2821","journal-title":"Arthritis Res Ther"},{"key":"8505_CR74","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","unstructured":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581\u2013590","journal-title":"Arthritis Rheum"},{"key":"8505_CR75","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, M\u00fcller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737\u20132747. doi: 10.1002\/art.38098","journal-title":"Arthritis Rheum"},{"key":"8505_CR76","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatology 15:202\u2013205","journal-title":"J Rheumatology"},{"key":"8505_CR77","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger TA (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573\u20131576","journal-title":"J Rheumatol"},{"key":"8505_CR78","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","volume":"70","author":"J Avouac","year":"2011","unstructured":"Avouac J, Fransen J, Walker UA, Riccieri V, Smith V, Muller C, Miniati I, Tarner IH, Randone SB, Cutolo M, Allanore Y, Distler O, Valentini G, Czirjak L, M\u00fcller-Ladner U, Furst DE, Tyndall A, Matucci-Cerinic M, EUSTAR Group (2011) Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 70:476\u2013481. doi: 10.1136\/ard.2010.136929","journal-title":"Ann Rheum Dis"},{"key":"8505_CR79","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(96)91687-6","volume":"347","author":"LG Fine","year":"1996","unstructured":"Fine LG, Denton CP, Korn J, de Crombrugghe B, Black CM (1996) Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy. Lancet 347:1453\u20131458","journal-title":"Lancet"},{"key":"8505_CR80","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","volume":"58","author":"M Koenig","year":"2008","unstructured":"Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet J-R, Rich E, Grodzicky T, Raymond Y, Sen\u00e9cal J-L (2008) Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 58:3902\u20133912. doi: 10.1002\/art.24038","journal-title":"Arthritis Rheum"},{"key":"8505_CR81","first-page":"51","volume-title":"Systemic sclerosis","author":"TA Medsger Jr","year":"1996","unstructured":"Medsger TA Jr, Steen VD (1996) Classification, prognosis. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams and Wilkins, Baltimore, pp 51\u201379"},{"key":"8505_CR82","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F","volume":"44","author":"LS Lonzetti","year":"2001","unstructured":"Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, Choquette D, Raymond Y, Sen\u00e9cal JL (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44:735\u2013736","journal-title":"Arthritis Rheum"},{"key":"8505_CR83","first-page":"2159","volume":"26","author":"TA Medsger","year":"1999","unstructured":"Medsger TA, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, Harris CA, Jablonska S, Jayson MI, Jimenez SA, Krieg T, Leroy EC, Maddison PJ, Russell ML, Schachter RK, Wollheim FA, Zacharaie H (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159\u20132167","journal-title":"J Rheumatol"},{"issue":"Suppl 29","key":"8505_CR84","first-page":"S42","volume":"21","author":"TA Medsger","year":"2003","unstructured":"Medsger TA, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21(Suppl 29):S42\u2013S46","journal-title":"Clin Exp Rheumatol"},{"key":"8505_CR85","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2010.104","volume":"6","author":"M Cutolo","year":"2010","unstructured":"Cutolo M, Sulli A, Smith V (2010) Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 6:578\u2013587. doi: 10.1038\/nrrheum.2010.104","journal-title":"Nat Rev Rheumatol"},{"key":"8505_CR86","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1006\/bcmd.2001.0443","volume":"27","author":"M Lima","year":"2001","unstructured":"Lima M, Teixeira MA, Queir\u00f3s ML, Leite M, Santos AH, Justi\u00e7a B, Orf\u00e3o A (2001) Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties. Blood Cells Mol Dis 27:731\u2013743","journal-title":"Blood Cells Mol Dis"},{"key":"8505_CR87","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.humimm.2006.08.292","volume":"67","author":"J Kelly-Rogers","year":"2006","unstructured":"Kelly-Rogers J, Madrigal-Estebas L, O'Connor T, Doherty DG (2006) Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro. Hum Immunol 67:863\u2013873","journal-title":"Hum Immunol"},{"key":"8505_CR88","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.150.2.246","volume":"150","author":"HS Ko","year":"1979","unstructured":"Ko HS, Fu SM, Wincheste R Jr, Yu DT, Kunkel HG (1979) Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med 150:246\u2013255","journal-title":"J Exp Med"},{"key":"8505_CR89","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-3083.1990.tb02917.x","volume":"32","author":"K Kristensson","year":"1990","unstructured":"Kristensson K, Dohlsten M, Fischer H, Ericsson PO, Hedlund G, Sj\u00f6gren HO, Carlsson R (1990) Phenotypical and functional differentiation of CD4+ CD45RA+ human T cells following polyclonal activation. Scand J Immunol 32:243\u2013253","journal-title":"Scand J Immunol"},{"key":"8505_CR90","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/intimm\/1.4.450","volume":"1","author":"M Merkenschlager","year":"1989","unstructured":"Merkenschlager M, Beverley PC (1989) Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: human CD8 memory CTLp selectively express CD45RO (UCHL1). Int Immunol 1:450\u2013459","journal-title":"Int Immunol"},{"key":"8505_CR91","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s004030050288","volume":"290","author":"T Wetzig","year":"1998","unstructured":"Wetzig T, Petri JB, Mittag M, Haustein UF (1998) Serum levels of soluble Fas\/APO-1 receptor are increased in systemic sclerosis. Arch Dermatol Res 290:187\u2013190","journal-title":"Arch Dermatol Res"},{"key":"8505_CR92","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00296-008-0799-x","volume":"29","author":"F Majone","year":"2009","unstructured":"Majone F, Olivieri S, Cozzi F, Montaldi A, Tonello M, Visentin MS, Ciprian L, Ruffatti A (2009) Increased apoptosis in circulating lymphocyte cultures of anti-RNA polymerase III positive patients with systemic sclerosis. Rheumatol Int 29:891\u2013895. doi: 10.1007\/s00296-008-0799-x","journal-title":"Rheumatol Int"},{"key":"8505_CR93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1023\/B:JOCI.0000018060.36183.bb","volume":"24","author":"A Kessel","year":"2004","unstructured":"Kessel A, Rosner I, Rozenbaum M, Zisman D, Sagiv A, Shmuel Z, Sabo E, Toubi E (2004) Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-kappa B. J Clin Immunol 24:30\u201336","journal-title":"J Clin Immunol"},{"key":"8505_CR94","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/rheumatology\/39.12.1341","volume":"39","author":"GH Stummvoll","year":"2000","unstructured":"Stummvoll GH, Aringer M, Smolen JS, K\u00f6ller M, Kiener HP, Steiner CW, Bohle B, Knobler R, Graninger WB (2000) Derangement of apoptosis-related lymphocyte homeostasis in systemic sclerosis. Rheumatology 39:1341\u20131350. doi: 10.1093\/rheumatology\/39.12.1341","journal-title":"Rheumatology"},{"key":"8505_CR95","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0090-1229(90)90147-I","volume":"56","author":"D Degiannis","year":"1990","unstructured":"Degiannis D, Seibold JR, Czarnecki M, Raskova J, Raska K (1990) Soluble and cellular markers of immune activation in patients with systemic sclerosis. Clin Immunol Immunopathol 56:259\u2013270","journal-title":"Clin Immunol Immunopathol"},{"key":"8505_CR96","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ard.50.6.354","volume":"50","author":"A Kahan","year":"1991","unstructured":"Kahan A, Kahan A, Picard F, Menk\u00e8s CJ, Amor B (1991) Abnormalities of T lymphocyte subsets in systemic sclerosis demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies. Ann Rheum Dis 50:354\u2013358","journal-title":"Ann Rheum Dis"},{"key":"8505_CR97","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/ard.58.11.719a","volume":"58","author":"E Dalkili\u00e7","year":"1999","unstructured":"Dalkili\u00e7 E, Dilek K, G\u00fcll\u00fcl\u00fc M, Yavuz M, Karako\u00e7 Y, Yurtkuran M, Budak F, G\u00f6ral G (1999) Lymphocyte phenotypes in systemic sclerosis. Ann Rheum Dis 58:719\u2013720","journal-title":"Ann Rheum Dis"},{"key":"8505_CR98","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2249.2002.01721.x","volume":"127","author":"A Koreck","year":"2002","unstructured":"Koreck A, Sur\u00e1nyi A, Sz\u00f6ny BJ, Farkas A, Bata-Cs\u00f6rg\u00f6 Z, Kem\u00e9ny L, Dobozy A (2002) CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clin Exp Immunol 127:176\u2013182","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 5","key":"8505_CR99","doi-asserted-by":"crossref","first-page":"v14","DOI":"10.1093\/rheumatology\/ken279","volume":"47","author":"B Kahaleh","year":"2008","unstructured":"Kahaleh B (2008) The microvascular endothelium in scleroderma. Rheumatology 47(Suppl 5):v14\u2013v15. doi: 10.1093\/rheumatology\/ken279","journal-title":"Rheumatology"},{"key":"8505_CR100","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/rheumatology\/keq094","volume":"49","author":"R Palma De","year":"2010","unstructured":"De Palma R, D\u2019Aiuto E, Vettori S, Cuoppolo P, Abbate G, Valentini G (2010) Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role? Rheumatology 49:1257\u20131266. doi: 10.1093\/rheumatology\/keq094","journal-title":"Rheumatology"},{"key":"8505_CR101","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","volume":"43","author":"R Sgonc","year":"2000","unstructured":"Sgonc R, Gruschwitz MS, Boeck G, Sepp N, Gruber J, Wick G (2000) Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 43:2550\u20132562. doi: 10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","journal-title":"Arthritis Rheum"},{"key":"8505_CR102","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","volume":"10","author":"J Baraut","year":"2010","unstructured":"Baraut J, Michel L, Verrecchia F, Farge D (2010) Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmun Rev 10:65\u201373. doi: 10.1016\/j.autrev.2010.08.003","journal-title":"Autoimmun Rev"},{"key":"8505_CR103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-94-007-6627-3_43","volume":"788","author":"A Stelmaszczyk-Emmel","year":"2013","unstructured":"Stelmaszczyk-Emmel A, Zawadzka-Krajewska A, Kopatys A, Demkow U (2013) Th1, Th2, Th17, and regulatory cytokines in children with different clinical forms of allergy. Adv Exp Med Biol 788:321\u2013328. doi: 10.1007\/978-94-007-6627-3_43","journal-title":"Adv Exp Med Biol"},{"key":"8505_CR104","doi-asserted-by":"crossref","first-page":"d12","DOI":"10.2741\/A171","volume":"2","author":"CA Feghali","year":"1997","unstructured":"Feghali CA, Wright TM (1997) Cytokines in acute and chronic inflammation. Front Biosci 2:d12\u2013d26","journal-title":"Front Biosci"},{"key":"8505_CR105","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1128\/CDLI.8.6.1097-1103.2001","volume":"8","author":"J Jason","year":"2001","unstructured":"Jason J, Archibald LK, Nwanyanwu OC, Byrd MG, Kazembe PN, Dobbie H, Jarvis WR (2001) Comparison of serum and cell-specific cytokines in humans. Clin Diagn Lab Immunol 8:1097\u20131103. doi: 10.1128\/CDLI.8.6.1097-1103.2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"8505_CR106","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2014.01.019","volume":"48\u201349","author":"M Mosca","year":"2014","unstructured":"Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S (2014) The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun 48\u201349:50\u201352","journal-title":"J Autoimmun"},{"key":"8505_CR107","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE (2015) Pathogenesis of systemic sclerosis. Front Immunol 6:272","journal-title":"Front Immunol"},{"issue":"1","key":"8505_CR108","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11926-014-0474-z","volume":"17","author":"S Bhattacharyya","year":"2015","unstructured":"Bhattacharyya S, Varga J (2015) Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis. Curr Rheumatol Rep 17(1):474","journal-title":"Curr Rheumatol Rep"},{"key":"8505_CR109","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2014.01.020","volume":"48\u201349","author":"E Maverakis","year":"2014","unstructured":"Maverakis E, Patel F, Kronenberg DG, Chung L, Fiorentino D, Allanore Y, Guiducci S, Hesselstrand R, Hummers LK, Duong C, Kahaleh B, Macgregor A, Matucci-Cerinic M, Wollheim FA, Mayes MD, Gershwin ME (2014) International consensus criteria for the diagnosis of Raynaud's phenomenon. J Autoimmun 48\u201349:60\u201365","journal-title":"J Autoimmun"},{"issue":"8","key":"8505_CR110","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/annrheumdis-2013-205013","volume":"73","author":"L Bon van","year":"2014","unstructured":"van Bon L, Cossu M, Loof A, Gohar F, Wittkowski H, Vonk M, Roth J, van den Berg W, van Heerde W, Broen JC, Radstake TR (2014) Proteomic analysis of plasma identifies the toll-like receptor agonists S100A8\/A9 as a novel possible marker for systemic sclerosis phenotype. Ann Rheum Dis 73(8):1585\u20131589","journal-title":"Ann Rheum Dis"},{"key":"8505_CR111","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaut.2014.01.008","volume":"48\u201349","author":"C Tani","year":"2014","unstructured":"Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M, Bombardieri S (2014) The diagnosis and classification of mixed connective tissue disease. J Autoimmun 48\u201349:46\u201349","journal-title":"J Autoimmun"},{"key":"8505_CR112","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2013.11.004","volume":"48\u201349","author":"M Hudson","year":"2014","unstructured":"Hudson M, Fritzler MJ (2014) Diagnostic criteria of systemic sclerosis. J Autoimmun 48\u201349:38\u201341","journal-title":"J Autoimmun"},{"issue":"7","key":"8505_CR113","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10067-014-2579-1","volume":"33","author":"CG Khor","year":"2014","unstructured":"Khor CG, Chen XL, Lin TS, Lu CH, Hsieh SC (2014) Rituximab for refractory digital infarcts and ulcers in systemic sclerosis. Clin Rheumatol 33(7):1019\u20131020","journal-title":"Clin Rheumatol"},{"key":"8505_CR114","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2013.01.012","volume":"41","author":"Y Luo","year":"2013","unstructured":"Luo Y, Wang Y, Wang Q, Xiao R, Lu Q (2013) Systemic sclerosis: genetics and epigenetics. J Autoimmun 41:161\u2013167","journal-title":"J Autoimmun"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8505-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-015-8505-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8505-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T09:12:52Z","timestamp":1599642772000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-015-8505-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,7]]},"references-count":114,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["8505"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8505-8","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,7]]}}}